The action of sulphonamide-folic reductase inhibitor combinations against normal and drug-resistant strains of rodent malaria.
D000818:Animals; D005493:Folic Acid Antagonists; D008288:Malaria / Q000188:drug therapy*; D051379:Mice; D002727:Proguanil / Q000627:therapeutic use; D011739:Pyrimethamine / Q000627:therapeutic use; D011743:Pyrimidines / Q000627:therapeutic use; D013412:Sulfadimethoxine / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use*
D005493:Folic Acid Antagonists; D011743:Pyrimidines; D013449:Sulfonamides; D013412:Sulfadimethoxine; D002727:Proguanil; D011739:Pyrimethamine